271 related articles for article (PubMed ID: 11153082)
1. Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy.
Keane NM; Price P; Stone SF; John M; Murray RJ; French MA
AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1991-6. PubMed ID: 11153082
[TBL] [Abstract][Full Text] [Related]
2. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
[TBL] [Abstract][Full Text] [Related]
3. An adaptation of recombinant vaccinia-based ELISPOT and intracellular cytokine staining for a comparative measurement of cellular immune responses in HIV-1 and HIV-2 infections in West Africa.
Eshofonie A; van der Loeff MS; Whittle H; Jaye A
Clin Exp Immunol; 2006 Dec; 146(3):471-8. PubMed ID: 17100767
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.
Villacres MC; Lacey SF; La Rosa C; Krishnan R; Auge C; Longmate J; Zaia JA; Leedom JM; Diamond DJ
J Infect Dis; 2001 Aug; 184(3):256-67. PubMed ID: 11443550
[TBL] [Abstract][Full Text] [Related]
5. Impaired IFN-gamma-secreting capacity in mycobacterial antigen-specific CD4 T cells during chronic HIV-1 infection despite long-term HAART.
Sutherland R; Yang H; Scriba TJ; Ondondo B; Robinson N; Conlon C; Suttill A; McShane H; Fidler S; McMichael A; Dorrell L
AIDS; 2006 Apr; 20(6):821-9. PubMed ID: 16549965
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility to opportunistic infections in HIV-infected patients with increased CD4 T-cell counts on antiretroviral therapy may be predicted by markers of dysfunctional effector memory CD4 T cells and B cells.
French M; Keane N; McKinnon E; Phung S; Price P
HIV Med; 2007 Apr; 8(3):148-55. PubMed ID: 17461858
[TBL] [Abstract][Full Text] [Related]
7. Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART.
Burgess K; Price P; James IR; Stone SF; Keane NM; Lim AY; Warmington JR; French MA
J Clin Immunol; 2006 Mar; 26(2):160-7. PubMed ID: 16568352
[TBL] [Abstract][Full Text] [Related]
8. Partial restoration of cytokine profile despite reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients during highly active antiretroviral treatment.
Alfonzo M; Blanc D; Troadec C; Eliaszewicz M; Gónzalez G; Scott-Algara D
Scand J Immunol; 2003 Apr; 57(4):375-83. PubMed ID: 12662301
[TBL] [Abstract][Full Text] [Related]
9. Quantitative and qualitative assessment of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cell immunity to gag in HIV-1-infected individuals with differential disease progression: reciprocal interferon-gamma and interleukin-10 responses.
Ostrowski MA; Gu JX; Kovacs C; Freedman J; Luscher MA; MacDonald KS
J Infect Dis; 2001 Nov; 184(10):1268-78. PubMed ID: 11679915
[TBL] [Abstract][Full Text] [Related]
10. Defective IL-2 production by HIV-1-specific CD4 and CD8 T cells in an adolescent/young adult cohort.
Kapogiannis BG; Henderson SL; Nigam P; Sharma S; Chennareddi L; Herndon JG; Robinson HL; Amara RR
AIDS Res Hum Retroviruses; 2006 Mar; 22(3):272-82. PubMed ID: 16545014
[TBL] [Abstract][Full Text] [Related]
11. Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
Weinberg A; Wohl DA; Barrett RJ; van der Horst C
J Infect Dis; 2001 Sep; 184(6):707-12. PubMed ID: 11517431
[TBL] [Abstract][Full Text] [Related]
12. Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface.
Shacklett BL; Cu-Uvin S; Beadle TJ; Pace CA; Fast NM; Donahue SM; Caliendo AM; Flanigan TP; Carpenter CC; Nixon DF
AIDS; 2000 Sep; 14(13):1911-5. PubMed ID: 10997394
[TBL] [Abstract][Full Text] [Related]
13. Long-term highly active antiretroviral therapy in chronic HIV-1 infection: evidence for reconstitution of antiviral immunity.
Jansen CA; Piriou E; De Cuyper IM; van Dort K; Lange JM; Miedema F; van Baarle D
Antivir Ther; 2006; 11(1):105-16. PubMed ID: 16518966
[TBL] [Abstract][Full Text] [Related]
14. Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.
Weinberg A; Tierney C; Kendall MA; Bosch RJ; Patterson-Bartlett J; Erice A; Hirsch MS; Polsky B;
J Infect Dis; 2006 Feb; 193(4):488-93. PubMed ID: 16425127
[TBL] [Abstract][Full Text] [Related]
15. Progressive reduction of CMV-specific CD4+ T cells in HIV-1 infected individuals during antiretroviral therapy.
Grosse V; Schulte A; Weber K; Mendila M; Jacobs R; Schmidt RE; Heiken H
Immunobiology; 2000 Aug; 202(2):179-85. PubMed ID: 10993292
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y
Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
[TBL] [Abstract][Full Text] [Related]
17. Rapid monitoring of immune reconstitution after allogeneic stem cell transplantation--a comparison of different assays for the detection of cytomegalovirus-specific T cells.
Abu-Khader A; Krause S
Eur J Haematol; 2013 Dec; 91(6):534-45. PubMed ID: 23952609
[TBL] [Abstract][Full Text] [Related]
18. Cytomegalovirus-specific cell-mediated immunity in HIV-infected children on HAART.
Weinberg A; Wiznia AA; Lafleur BJ; Shah S; Levin MJ
AIDS Res Hum Retroviruses; 2006 Mar; 22(3):283-8. PubMed ID: 16545015
[TBL] [Abstract][Full Text] [Related]
19. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
[TBL] [Abstract][Full Text] [Related]
20. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
